456 A Phase 1b/2 Umbrella Study of Anti-Pd-1 Sasanlimab in Combination with Other Therapies for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC): the LANDSCAPE 1011 Trial in Progress
Regular and Young Investigator Award Abstracts（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined